PubRank

N S Young

Author PubWeight™ 240.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000 4.99
2 Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994 4.86
3 Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993 4.12
4 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. N Engl J Med 1982 3.29
5 A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 1983 3.02
6 Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987 2.93
7 Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med 1972 2.79
8 High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 2000 2.75
9 An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest 1972 2.61
10 Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A 1991 2.55
11 Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000 2.42
12 Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 1985 2.33
13 Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 1996 2.26
14 Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999 2.17
15 Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989 2.08
16 Hepatitis-associated aplastic anemia. N Engl J Med 1997 1.98
17 Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 1996 1.97
18 Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 1988 1.97
19 Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol 1999 1.97
20 Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995 1.91
21 Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 2001 1.89
22 Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995 1.85
23 Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989 1.85
24 Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci U S A 1992 1.82
25 Characterization of a virus that causes transient aplastic crisis. J Clin Invest 1984 1.78
26 Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992 1.76
27 Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 1993 1.76
28 Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 1994 1.75
29 Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 1989 1.69
30 Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Intern Med 1984 1.66
31 Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat Med 1995 1.65
32 Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 1992 1.63
33 Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997 1.63
34 Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989 1.56
35 Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996 1.56
36 Correction of the PNH defect by GPI-anchored protein transfer. Blood 1998 1.55
37 Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood 1997 1.55
38 Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3. Br J Haematol 1991 1.50
39 A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol 1992 1.48
40 Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura. J Thromb Haemost 2012 1.47
41 Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999 1.47
42 Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994 1.45
43 Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993 1.45
44 Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 1985 1.43
45 Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986 1.42
46 Fanconi anemia and novel strategies for therapy. Blood 1994 1.39
47 Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994 1.39
48 The structure of human parvovirus B19 at 8 A resolution. Virology 1994 1.38
49 Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 1984 1.38
50 Association of seropositivity for hepatitis viruses and aplastic anemia in Thailand. Hepatology 1997 1.38
51 Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995 1.33
52 Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996 1.32
53 A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol 1994 1.30
54 Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A 1996 1.29
55 Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc Natl Acad Sci U S A 1994 1.28
56 Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994 1.28
57 Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 1999 1.28
58 Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 1999 1.27
59 Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995 1.27
60 gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994 1.26
61 Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J Clin Invest 1994 1.26
62 Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997 1.26
63 Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992 1.25
64 Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest 2001 1.25
65 A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 1996 1.24
66 Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood 2001 1.24
67 Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 1985 1.23
68 Infection of mononucleated phagocytes with human cytomegalovirus. Virology 1993 1.23
69 A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A 1989 1.22
70 First continuous propagation of B19 parvovirus in a cell line. Blood 1992 1.22
71 Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia 2011 1.21
72 The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986 1.20
73 Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood 1998 1.19
74 Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997 1.17
75 Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood 1997 1.16
76 Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 2006 1.16
77 Cloning and sequencing of the simian parvovirus genome. Virology 1995 1.15
78 A knock-out model of paroxysmal nocturnal hemoglobinuria: Pig-a(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins. Proc Natl Acad Sci U S A 1996 1.13
79 Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994 1.13
80 Goose parvovirus--an autonomous member of the dependovirus genus? Virology 1995 1.13
81 Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells. Virology 1991 1.11
82 Persistent parvovirus B19 infections in humans. Microb Pathog 1989 1.11
83 HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 1994 1.11
84 Parvoviruses and bone marrow failure. Stem Cells 1996 1.11
85 Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993 1.10
86 Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001 1.09
87 Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production. Blood 1986 1.08
88 A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. J Virol 1991 1.07
89 Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Blood 1991 1.07
90 Parvovirus B19 infection and hematopoiesis. Blood Rev 1995 1.06
91 Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 2003 1.06
92 Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) 1988 1.06
93 Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995 1.05
94 Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 1996 1.04
95 A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction. J Virol Methods 1991 1.04
96 Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood 1997 1.04
97 Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. Blood 1997 1.03
98 Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 1995 1.03
99 Biological and immunological characterization of ATG and ALG. Blood 1986 1.02
100 Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Exp Hematol 2001 1.02
101 Hematologic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukin-2 in cancer patients. Blood 1987 1.02
102 Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion 2000 1.01
103 Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA 1992 1.01
104 Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Br J Haematol 2001 1.01
105 Hemoglobin switching in sheep: only the gamma gene is in the active conformation in fetal liver but all the beta and gamma genes are in the active conformation in bone marrow. Proc Natl Acad Sci U S A 1978 1.01
106 Patient-specific transfusion-related acute lung injury. Vox Sang 2008 1.00
107 Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 1995 1.00
108 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin. J Clin Invest 1985 1.00
109 Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol 2000 0.99
110 Isolation of antibodies specific to sickle hemoglobin by affinity chromatography using a synthetic peptide. Proc Natl Acad Sci U S A 1975 0.99
111 Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells. Br J Haematol 1997 0.98
112 Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells. Leukemia 2005 0.98
113 Experimental infection of cynomolgus monkeys with simian parvovirus. J Virol 1997 0.98
114 Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997 0.97
115 A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 1994 0.97
116 T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplant 1998 0.97
117 Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 1994 0.96
118 Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001 0.95
119 Viruses and bone marrow failure. Blood Rev 1991 0.95
120 Clinical and epidemiological features of simian parvovirus infection in cynomolgus macaques with severe anemia. Lab Anim Sci 1996 0.95
121 A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med 1984 0.95
122 Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 1995 0.95
123 CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies. Br J Haematol 2000 0.95
124 Aplastic anaemia in the Orient. Br J Haematol 1986 0.94
125 Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood 1985 0.94
126 Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group. Am J Public Health 1997 0.92
127 Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back. Br J Haematol 2001 0.92
128 Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 1994 0.92
129 Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991 0.92
130 Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia 2005 0.92
131 Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients. Hum Gene Ther 1997 0.92
132 Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS 1997 0.91
133 Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. J Virol 1994 0.91
134 Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia. Ann N Y Acad Sci 1985 0.90
135 Epstein-Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 1988 0.90
136 B19 parvovirus replicates in circulating cells of acutely infected patients. Blood 1988 0.90
137 Regional patterns in the incidence of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Am J Hematol 1999 0.89
138 High prevalence of GB virus C/hepatitis G virus in healthy persons in Ho Chi Minh City, Vietnam. J Infect Dis 1997 0.89
139 Parvovirus B19 infection and bone marrow transplantation. Ann Hematol 1992 0.89
140 The transcriptional regulator YY1 binds to the 5'-terminal region of B19 parvovirus and regulates P6 promoter activity. J Virol 1994 0.88
141 Parvovirus particles as platforms for protein presentation. Proc Natl Acad Sci U S A 1994 0.88
142 Fanconi anemia presenting unexpectedly in an adult kindred with no dysmorphic features. Am J Med 1991 0.87
143 Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J Virol 1995 0.87
144 A new syndrome of familial aplastic anemia and chronic liver disease. Acta Haematol 1997 0.87
145 Polymerase chain reaction for detection of parvovirus B19 in immunodeficient patients with anemia. Behring Inst Mitt 1990 0.86
146 Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG. J Virol Methods 1993 0.86
147 Expression of interferon-gamma by stromal cells inhibits murine long-term repopulating hematopoietic stem cell activity. Exp Hematol 1999 0.86
148 Oral manifestations in patients with aplastic anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 0.86
149 Antithymocyte globulin hypersensitivity in bone marrow failure patients. JAMA 1988 0.86
150 Subunit interaction in B19 parvovirus empty capsids. Arch Virol 1994 0.86
151 Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro. J Exp Med 1985 0.86
152 Parvovirus B19 in human disease. Annu Rev Med 1997 0.86
153 The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia. Bone Marrow Transplant 2003 0.86
154 Autoimmunity and its treatment in aplastic anemia. Ann Intern Med 1997 0.85
155 Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 1994 0.85
156 Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 1999 0.84
157 Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patients. Pediatr Infect Dis J 2000 0.84
158 Upstream sequences within the terminal hairpin positively regulate the P6 promoter of B19 parvovirus. Virology 1991 0.84
159 Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. Am J Hematol 2000 0.84
160 Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 1993 0.84
161 Antibodies to an NH2-terminal fragment of betaS globin. II. Specificity and isolation of antibodies for the sickle mutation. J Biol Chem 1976 0.84
162 Feline parvovirus propagates in cat bone marrow cultures and inhibits hematopoietic colony formation in vitro. Blood 1989 0.84
163 Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia. Leukemia 2013 0.83
164 Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. Blood 1995 0.82
165 Serum sickness and haematopoietic recovery with antithymocyte globulin in bone marrow failure patients. Br J Haematol 1986 0.82
166 In situ hybridisation and in situ polymerase chain reaction detection of parvovirus B19 DNA within cells. J Virol Methods 1994 0.82
167 The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J Clin Invest 1998 0.82
168 Prevalence of GBV-C/HGV, a novel 'hepatitis' virus, in patients with aplastic anaemia. Br J Haematol 1997 0.82
169 Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. Leukemia 1998 0.82
170 Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff. Infect Control Hosp Epidemiol 1992 0.81
171 Gamma interferon and aplastic anemia. Blood 1987 0.81
172 Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential. Exp Hematol 1998 0.81
173 Successful surgical management of neutropenic enterocolitis in two patients with severe aplastic anemia. Case reports and review of the literature. Arch Intern Med 1993 0.80
174 Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations. Eur J Clin Invest 2009 0.80
175 Paroxysmal nocturnal hemoglobinuria: new insights from murine Pig-a-deficient hematopoiesis. Proc Assoc Am Physicians 1997 0.80
176 Use of household pesticides and the risk of aplastic anaemia in Thailand. The Aplastic Anemia Study Group. Int J Epidemiol 1997 0.80
177 Human parvovirus B19 infections in infants and children. Adv Pediatr Infect Dis 1997 0.80
178 Anti-K562 cell monoclonal antibodies recognize hematopoietic progenitors. Proc Natl Acad Sci U S A 1981 0.79
179 A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemia. Br J Haematol 1992 0.79
180 Regulation of human globin gene expression in mouse erythroleukemia x human fibroblast hybrid cells. Somatic Cell Genet 1982 0.79
181 GB virus C/Hepatitis G virus infection is frequent in American children and young adults. Clin Infect Dis 2000 0.79
182 Research directions in paroxysmal nocturnal hemoglobinuria. Immunol Today 1999 0.78
183 Introduction: acquired aplastic anemia. Semin Hematol 2000 0.78
184 Preliminary X-ray crystallographic investigation of human parvovirus B19. Virology 1991 0.78
185 Gene marking and gene therapy directed at primary hematopoietic cells. Curr Opin Hematol 1996 0.78
186 Human parvovirus B19 can infect cynomolgus monkey marrow cells in tissue culture. J Virol 1995 0.78
187 5-azacytidine for beta thalassaemia? Lancet 1983 0.78
188 Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure. Exp Hematol 1992 0.78
189 Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay. J Infect Dis 1999 0.78
190 A trial of recombinant human superoxide dismutase in patients with Fanconi anaemia. Br J Haematol 1993 0.78
191 Lack of evidence for parvovirus B19 viraemia in children with chronic neutropenia. Br J Haematol 1994 0.77
192 High prevalence of hepatitis C viremia among aplastic anemia patients and controls from Thailand. Am J Trop Med Hyg 1992 0.77
193 Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin. J Am Acad Dermatol 1985 0.77
194 Sequencing and characterization of A-2 plaque virus: A new member of the Picornaviridae family. Virology 2000 0.77
195 Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria. Thromb Res 1996 0.76
196 Anti-K562 monoclonal antibodies that recognize antigens on immature hematopoietic cells. Prog Clin Biol Res 1983 0.75
197 Reduced vitamin a levels of chicks fed anaerobically digested sewage sludge. Poult Sci 1981 0.75
198 Urinary fibrin split products in lupus nephritis. J Rheumatol 1976 0.75
199 Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphoblastic leukemia, mimicking leukemic relapse. Am J Hematol 1995 0.75
200 A trial of immunotherapy in aplastic anemia and pure red cell aplasia. J Clin Apher 1983 0.75
201 A study of human serum sickness. J Invest Dermatol 1985 0.75
202 Purification of functional recombinant YY1 expressed in Sf9 insect cells. Protein Expr Purif 1995 0.75
203 Epidemiology and pathology of erythroviruses. Contrib Microbiol 2000 0.75
204 Comprehensive Dental Hygiene Care. Periodontal debridement. Part 2. RDH 1993 0.75
205 [Hypoproliferative disorders of stem cells]. Rev Invest Clin 1997 0.75
206 Viruses, virulence and pathogenicity. Baillieres Clin Haematol 1995 0.75
207 The human parvovirus and in vitro hematopoietic colony formation. Prog Clin Biol Res 1984 0.75
208 RMRP mutations in hematological disorders. Clin Genet 2007 0.75
209 Acquired sideroblastic anaemia following progesterone therapy. Br J Haematol 1994 0.75
210 Viruses and the blood. Baillieres Clin Haematol 1992 0.75
211 Human serum sickness. Trans Assoc Am Physicians 1984 0.75
212 The NH2-terminal region of the sickle hemoglobin beta chain. II. Characterization of monospecific antibodies. J Biol Chem 1976 0.75
213 Comprehensive Dental Hygiene Care. Periodontal debridement. Part 1. RDH 1993 0.75
214 Etiologic mechanisms of hematopoietic failure. Am J Pediatr Hematol Oncol 1990 0.75
215 Different haematopoietic growth factors have different capacity in overcoming the in vitro interferon gamma-induced suppression of bone marrow progenitor cells. Eur J Haematol 1990 0.75
216 Instrumentation. Dent Hyg (Chic) 1980 0.75
217 Autoimmune aspects of aplastic anemia. In Vivo 1992 0.75